Mirae Asset Global ETFs Holdings’s Global X Genomics & Biotechnology ETF GNOM Stock Holding History

Mirae Asset Global ETFs Holdings’s Portfolio GNOM Stock Details GNOM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-33,378	Closed	-$1.06M	–	3092
2025 Q1	$1.06M	Sell	33,378 -224	-0.7%	-$8.5K	﹤0.01%	1467
2024 Q4	$1.31M	Sell	33,602 -3,317	-9%	-$139K	﹤0.01%	1406
2024 Q3	$1.66M	Sell	36,919 -13,003	-26%	-$581K	﹤0.01%	1245
2024 Q2	$2.08M	Buy	+49,922	New	+$2.09M	0.01%	1057

Other funds holding GNOM

FTUS

Flow Traders U.S. New York $3.16B AUM 19.52% 1-Year Est. Return

LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

OAM

Oppenheimer Asset Management New York $8.76B AUM 23.12% 1-Year Est. Return

IWM

IHT Wealth Management Chicago, Illinois $4.3B AUM 21.02% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Insight Advisors Newtown, Pennsylvania $525M AUM 15.94% 1-Year Est. Return

SWP

Stratos Wealth Partners Beachwood, Ohio $8.8B AUM 21.82% 1-Year Est. Return

OCM

One Capital Management Westlake Village, California $3.65B AUM 15.32% 1-Year Est. Return

Mirae Asset Global ETFs Holdings's GNOM Position: Q2 2025 in Review

Mirae Asset Global ETFs Holdings sold out of Global X Genomics & Biotechnology ETF (GNOM) in Q2 2025, closing a stake of 33,378 shares — an estimated $1.06M sold.

Mirae Asset Global ETFs Holdings first reported a position in GNOM in Q2 2024 and held it in 4 quarters. The position peaked at $2.08M in Q2 2024. 51 funds tracked by Wall St. Rank hold GNOM as of Q2 2025.

Mirae Asset Global ETFs Holdings reported no remaining Global X Genomics & Biotechnology ETF position as of Q2 2025 after selling out during the quarter.
Mirae Asset Global ETFs Holdings sold 33,378 Global X Genomics & Biotechnology ETF shares in Q2 2025, an estimated $1.06M.
Mirae Asset Global ETFs Holdings first reported a position in Global X Genomics & Biotechnology ETF in Q2 2024 and held it in 4 quarters.
Mirae Asset Global ETFs Holdings's Global X Genomics & Biotechnology ETF position peaked at $2.08M in Q2 2024.
51 funds tracked by Wall St. Rank held Global X Genomics & Biotechnology ETF as of Q2 2025.

Based on Mirae Asset Global ETFs Holdings's 13F filing for Q2 2025, filed 14 Aug 2025.